National Data Opt-out and what it means to cancer patients
Cancer52, together with use MY data, has produced a briefing paper entitled National Data Opt-out and what it means to cancer patients....
Cancer Strategy recommendations grid April
As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer...
Briefing paper on the New Cancer Drug Fund Operating Model
On 28th July 2016 Cancer52 published its Cancer52 Position Paper on the new Cancer Drugs Fund Operating Model FINAL 28th July 2016.